About the Laboratory

Our breast cancer research team discovers molecular biomarkers or signatures that can be translated into clinically-relevant modalities, and elucidate the underlying pathophysiology that predisposes or cause breast cancer.

We create tools for personalized medicine leading to reduce cancer risk, incidence, morbidity and mortality, and improve screening, treatment, and survivorship.

We are both a wet- and dry-lab equipped for molecular biology and histology, and computational biology.

We collaborate with our BIDMC breast pathologists and oncologists, and the Nurses' Health Study.

TCGA invasive breast cancer annotations (published in J.Path 2017), previously on www.dx.ai/tcga_breast are now located here - http://legacy.dx.ai/tcga_breast/